Trial Profile
A single-center trial of sofosbuvir for the treatment of patients with hepatitis C infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record